SEC Comment Letter for Zeo ScientifiX, Inc. (ZEOX) (CIK 0001557376) (ZEOX) — Sep 29, 2022
Zeo ScientifiX, Inc. (ZEOX) (CIK 0001557376)
Date: Sept. 29, 2022 · CIK: 0001557376 · Accession: 0000000000-22-010720
AI Filing Summary & Sentiment
File numbers found in text: 333-267563
Letter
United States securities and exchange commission logo September 29, 2022 Ian Bothwell Chief Financial Officer Organicell Regenerative Medicine, Inc. 1951 NW 7th Ave, Suite 300 Miami, Florida, 33136 Re:Organicell Regenerative Medicine, Inc. Registration Statement on Form S-1 Filed September 22, 2022 File No. 333-267563 Dear Mr. Bothwell: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Gregory Herbers at 202-551-8028 with any questions. Sincerely, Division of Corporation Finance Office of Manufacturing cc: Dale S. Bergman
Show Raw Text
United States securities and exchange commission logo
September 29, 2022
Ian Bothwell
Chief Financial Officer
Organicell Regenerative Medicine, Inc.
1951 NW 7th Ave, Suite 300
Miami, Florida, 33136
Re:Organicell Regenerative Medicine, Inc.
Registration Statement on Form S-1
Filed September 22, 2022
File No. 333-267563
Dear Mr. Bothwell:
This is to advise you that we have not reviewed and will not review your registration
statement.
Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you
that the company and its management are responsible for the accuracy and adequacy of their
disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Please contact Gregory Herbers at 202-551-8028 with any questions.
Sincerely,
Division of Corporation Finance
Office of Manufacturing
cc: Dale S. Bergman